Search
for
Sort by
Research 91–120 of 1000+
- The role of oclacitinib in the management of ischaemic dermatopathy in four dogs
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Folliculitis decalvans responsive to tofacitinib: A case series
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- SDRIFE Induced by Tofacitinib
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Alopecia – New building blocks
- Topical tofacitinib in treatment of alopecia areata
- Alopecia areata-like hair loss after a tick bite
- Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Alopecia universalis. Partial response to tofacitinib
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms